SCHEMBL20127412

SCHEMBL20127412

c1ccc2c(-c3c4ccccc4c(-c4cc5c6ccccc6oc5c5ccccc45)c4ccccc34)c3ccc4ccccc4c3cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.47
ALDH1A1 P00352 4/20 0.41
HSD17B10 Q99714 3/20 0.41
HIF1A Q16665 1/20 0.41
CYP1B1 Q16678 1/20 0.41
DYRK1A Q13627 1/20 0.38
AHR P35869 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ALOX5 P09917 2/20 0.37
ARSA P15289 1/20 0.36
CDC25A P30304 1/20 0.36
CDC25C P30307 1/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPT P10636 3/20 0.36
KMT2A Q03164 2/20 0.36
RAB9A P51151 2/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127445 0.88 ALDH1A1 (0.46) SOS1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL20127674 0.88 SOS1 (0.47) SOS1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL20127395 0.88 ALOX5 (0.41) SOS1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL20127399 0.87 ALOX5 (0.43) SOS1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL20127635 0.87 ALDH1A1 (0.44) SOS1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL10122448 0.87 AHR (0.42) ALDH1A1HSD17B10HIF1ACYP1B1DYRK1A
SCHEMBL20127439 0.85 SOS1 (0.46) SOS1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL10122560 0.84 AHR (0.41) SOS1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL20412629 0.84 ALOX5 (0.41) SOS1ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL10122690 0.83 AHR (0.50) ALDH1A1HSD17B10DYRK1AAHRALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 SOS1 960/4885ALDH1A1 476/4885HSD17B10 2025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.